Viewing Study NCT02029950


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2026-01-04 @ 6:02 PM
Study NCT ID: NCT02029950
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2014-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2013-02426
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators